Kura Oncology Inc (KURA)
17.52
-0.30
(-1.71%)
USD |
NASDAQ |
Nov 05, 16:00
17.52
0.00 (0.00%)
After-Hours: 16:11
Kura Oncology Enterprise Value: 883.53M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 883.53M |
| November 01, 2024 | 811.49M |
| October 31, 2024 | 799.23M |
| October 30, 2024 | 818.39M |
| October 29, 2024 | 848.28M |
| October 28, 2024 | 876.63M |
| October 25, 2024 | 859.77M |
| October 24, 2024 | 880.47M |
| October 23, 2024 | 822.22M |
| October 22, 2024 | 849.05M |
| October 21, 2024 | 874.33M |
| October 18, 2024 | 897.32M |
| October 17, 2024 | 904.22M |
| October 16, 2024 | 918.02M |
| October 15, 2024 | 913.42M |
| October 14, 2024 | 901.92M |
| October 11, 2024 | 941.77M |
| October 10, 2024 | 915.72M |
| October 09, 2024 | 921.85M |
| October 08, 2024 | 909.59M |
| October 07, 2024 | 888.90M |
| October 04, 2024 | 900.39M |
| October 03, 2024 | 911.12M |
| October 02, 2024 | 935.64M |
| October 01, 2024 | 990.05M |
| Date | Value |
|---|---|
| September 30, 2024 | 1.015B |
| September 27, 2024 | 1.014B |
| September 26, 2024 | 1.009B |
| September 25, 2024 | 1.018B |
| September 24, 2024 | 1.037B |
| September 23, 2024 | 1.067B |
| September 20, 2024 | 1.123B |
| September 19, 2024 | 1.133B |
| September 18, 2024 | 1.071B |
| September 17, 2024 | 1.063B |
| September 16, 2024 | 1.117B |
| September 13, 2024 | 1.118B |
| September 12, 2024 | 1.042B |
| September 11, 2024 | 1.041B |
| September 10, 2024 | 1.031B |
| September 09, 2024 | 1.017B |
| September 06, 2024 | 996.18M |
| September 05, 2024 | 1.026B |
| September 04, 2024 | 1.038B |
| September 03, 2024 | 1.067B |
| August 30, 2024 | 1.132B |
| August 29, 2024 | 1.090B |
| August 28, 2024 | 1.061B |
| August 27, 2024 | 1.072B |
| August 26, 2024 | 1.092B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
63.62M
Minimum
Mar 18 2020
2.430B
Maximum
Dec 11 2020
725.11M
Average
609.92M
Median
Enterprise Value Benchmarks
| AIM ImmunoTech Inc | 8.843M |
| Perspective Therapeutics Inc | 530.78M |
| Protalix BioTherapeutics Inc | 69.53M |
| Electromed Inc | 180.63M |
| Armata Pharmaceuticals Inc | 170.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -50.84M |
| Total Expenses (Quarterly) | 56.40M |
| EPS Diluted (Quarterly) | -0.59 |
| Earnings Yield | -12.73% |